Last reviewed · How we verify
Omeprazole and domperidone — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Omeprazole and domperidone (Omeprazole and domperidone) — Mansoura University Children Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Omeprazole and domperidone TARGET | Omeprazole and domperidone | Mansoura University Children Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Omeprazole and domperidone CI watch — RSS
- Omeprazole and domperidone CI watch — Atom
- Omeprazole and domperidone CI watch — JSON
- Omeprazole and domperidone alone — RSS
Cite this brief
Drug Landscape (2026). Omeprazole and domperidone — Competitive Intelligence Brief. https://druglandscape.com/ci/omeprazole-and-domperidone. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab